WHO Pharmaceuticals Newsletter 1998, No. 09&10
(1998; 23 pages)
Table des matières
Ouvrir ce répertoire et afficher son contenuRegulatory decisions
Ouvrir ce répertoire et afficher son contenuDrug surveillance
Ouvrir ce répertoire et afficher son contenuNew developments
Fermer ce répertoireMedical devices
Afficher le documentBlood glucose meters - recalled because of error readings: USA
Afficher le documentEpiPen epinephrine auto-injectors - recall of syringes: Switzerland
Afficher le documentMedical devices - the year 2000 problem: guidance document: USA
Afficher le documentSkin wound closure adhesive - approved: USA
Afficher le documentWeight loss device - recalled: USA
Ouvrir ce répertoire et afficher son contenuGeneral information
Ouvrir ce répertoire et afficher son contenuMedication errors
Ouvrir ce répertoire et afficher son contenuVeterinary medicine
 

EpiPen epinephrine auto-injectors - recall of syringes: Switzerland

Switzerland. Following the alerts concerning the recall by the manufacturer, Meridian Medical Technologies Inc., of the EpiPen and the EpiPen Junior Autoinjectors because some 10% of units were found to be ineffective due to damage during the manufacturing process, the Intercantonal Office for the Control of Medicines has recalled the following batches:

EpiPen: 806 509, 725 902, 732 213
EpiPen Junior: 806 507, 725 901, 732 215.

Patients are advised to return immediately the defective syringes to their doctor or pharmacist and exchange them with new syringes. In the interim, patients are advised to used the syringes they have in an emergency.

[See also Pharmaceuticals Newsletter Nos. 7&8, July&August 1998]

Reference: Schweizer Apothekerzeitung, 16/98.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013